Hughes Hubbard & Reed LLP represented ANI Pharmaceuticals in the transaction. ANI Pharmaceuticals signed an agreement to acquire Novitium Pharma for $89.5 million in cash and $74 million...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here